Showing results (141-150 of 171) with videos related to
Sort By:
Pageof 18
Annals of the New York Academy of Sciences|September 29, 2011
Barrett's esophagus: treatments of adenocarcinomas IIWilliam S Twaddell, Peter C Wu, Roy J J Verhage, et al.Annals of Surgery|July 12, 2023
Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision OncologyMiseker Abate, Henry Walch, Kanika Arora, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 13, 2021
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS studyWasat Mansoor, Hendrik-Tobias Arkenau, Maria Alsina, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 5, 2020
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGSJosep Tabernero, Maria Alsina, Kohei Shitara, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal AdenocarcinomaSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.The Oncologist|December 2, 2025
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studiesYeon Hee Park, Javier Cortes, Shanu Modi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal CancerSamuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, et al.The Lancet. Oncology|October 26, 2018
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trialKohei Shitara, Toshihiko Doi, Mikhail Dvorkin, et al.Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.The Journal of Thoracic and Cardiovascular Surgery|November 24, 2024
Esophagectomy may have a role in stage IV esophageal adenocarcinomaMarisa Sewell, Nicolas Toumbacaris, Kay See Tan, et al.Pageof 18